Federal contract award
N6523619C8016
IGF::OT::IGF DARPA - BAA: HR001118S0029 PHASE I - INCREMENTALLY FUNDED CONTRACT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DCMA MID-ATLANTIC |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AD92 — OTHER DEFENSE - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $8.8M |
| Current contract value | $10.1M |
| Potential contract value / ceiling | $17.0M |
| Start date | Apr 5, 2019 |
| Current end date | Mar 14, 2020 |
| Potential end date | Mar 14, 2020 |
| Latest award activity | Jul 25, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 25, 2025 | A00001 | $-7.0K | DARPA - BAA: HR001118S0029 PHASE I - INCREMENTALLY FUNDED CONTRACT |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BAA Coordinator N3@darpa.mil | Contact | Contact method not published | Source | Mar 23, 2018 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.